Transdermal Flurbiprofen Delivery Using HPMC Matrices: Design, in Vitro and in Vivo Evaluation
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 23 (7) , 633-638
- https://doi.org/10.3109/03639049709150763
Abstract
A matrix-dispersion-type transdermal drug delivery system of flurbiprofen was designed and developed using different concentrations and grades of hydroxypropyl methylcellulose (HPMC). Formulations were selected on the basis of their drug release content and release pattern. These were evaluated for in vitro dissolution characteristics using a Cygnus sandwich-patch holder. The release followed Higuchi kinetics, as its coefficient of correlation (r = 0.977-0.990; p < 0.001) predominates over the other release kinetics. In vivo evaluation was carried out on healthy rabbits, following the balanced incomplete block design. The in vitro dissolution rate constant and pharmacokinetic parameters were evaluated statistically by two-way analysis of variance (ANOVA). A significant difference was found between the test products (p < 0.01), but not within the test products (p > 0.05).Keywords
This publication has 7 references indexed in Scilit:
- Communications Drug Carriers for Transdermal Preparations of FlurbiprofenDrug Development and Industrial Pharmacy, 1994
- New improved paddle method for determining the in vitro drug release profiles of transdermal delivery systemsJournal of Controlled Release, 1993
- Skin compatibility of transdermal drug delivery systemsJournal of Controlled Release, 1991
- Transdermal Drug Delivery - Problems and PromisesDrug Development and Industrial Pharmacy, 1988
- In vitro dissolution profile of transdermal nitroglycerin patches using paddle methodInternational Journal of Pharmaceutics, 1986
- Interpretation and prediction of the kinetics of transdermal drug delivery: oestradiol, hyoscine and timololInternational Journal of Pharmaceutics, 1986
- FlurbiprofenDrugs, 1979